Related Experiment Video
Updated: Feb 11, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Evaluating the effectiveness of systemic corticosteroids to mitigate relapse in children assessed and treated for
Scott W Kirkland1, Ben Vandermeer2, Sandy Campbell3
1a Department of Emergency Medicine , University of Alberta , Edmonton , AB , Canada.
Insights
Systemic corticosteroids (SCS) effectively reduce asthma relapse in children after hospital discharge. Specific regimens like intramuscular corticosteroids, short-course oral prednisone, and oral dexamethasone showed significant benefits compared to placebo.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
- Evidence-Based Medicine
Background:
- Asthma relapse post-acute care is a significant concern in pediatric patients.
- Systemic corticosteroids (SCS) are commonly used, but optimal regimens for relapse prevention require clarification.
Purpose of the Study:
- To systematically review the effectiveness of various systemic corticosteroid (SCS) regimens in preventing asthma relapse in children discharged from acute care.
Main Methods:
- Comprehensive literature search across multiple databases (Medline, EMBASE, etc.) and clinical trial registries.
- Inclusion of randomized controlled trials without language, publication status, or year limitations.
- Two independent reviewers assessed study eligibility and extracted data.
Main Results:
- Fifteen studies were included in the analysis.
- SCS significantly reduced asthma relapse compared to placebo (RR = 0.10; 95% CI: 0.01, 0.77).
- Network analysis revealed significant relapse reduction with intramuscular corticosteroids, short-course oral prednisone, and oral dexamethasone versus placebo.
Conclusions:
- Systemic corticosteroids demonstrate efficacy in reducing asthma relapse in children post-acute care.
- Further research is needed to determine optimal SCS doses and treatment durations for relapse prevention.
Objective:
The objective of this systematic review was to explore the effectiveness of various systemic corticosteroid (SCS) regimens to mitigate relapse in children with asthma discharged from an acute care setting.
Data Sources:
Medline, EMBASE, Global Health, International Pharmaceutical Abstracts, EMB ALL, CINAHL, SCOPUS, Proquest Dissertations and Theses Global, and LILACS were searched using controlled vocabulary and key words. Additional citations were searched via clinical trial registries, Google Scholar, bibliographies, a SCOPUS forward search of a sentinel paper, and hand searching conference abstracts.
Study Selection:
No limitations based on language, publication status, or year of publication were applied. Two independent reviewers searched to identify randomized controlled trials comparing the effectiveness of SCS regimens to prevent relapse in children following treatment for acute asthma.
Results:
Fifteen studies were included. In 3 studies comparing SCS to placebo, asthma relapse was significantly reduced (RR = 0.10; 95% CI: 0.01, 0.77; I2 = 0%). A network analysis identified a significant reduction in relapse in children treated with intramuscular corticosteroids (OR = 0.038; 95% CrI: 0.001, 0.397), short-course oral prednisone (OR = 0.054; 95% CrI: 0.002, 0.451), and oral dexamethasone (OR = 0.071; 95% CrI: 0.002, 0.733) compared to placebo.
Conclusion:
This review found evidence that SCS reduces relapse in children following treatment for acute asthma, albeit based on a limited number of studies. Additional studies are required to assess the differential effect of SCS doses and treatment duration to prevent relapse in children following discharge for acute asthma.
Related Concept Videos
Asthma-I: Introduction
COPD: Management Using Bronchodilators and Corticosteroids
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

